Teicobiotic (Teicoplanin) Injection

Generic brands for Teicoplanin Injection Available in India Brand Name Teicobiotic Generic Name Teicoplanin Strength 400mg Manufacturer Neon Laboratories Ltd

Description

Description

This page contains brief details about the drug teicoplanin, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.

Date of Approval

Teicoplanin is an antibiotic that belongs to the class of medications called semisynthetic glycopeptide. The FDA approved this medicine for its use on 24 May 2018. FDA did not approve it for use in the USA.

Mechanism of Action of Teicoplanin

The cell wall of gram-positive bacteria is entirely made of peptidoglycan, which is necessary for cell wall synthesis. Teicoplanin interferes with the cell-wall biosynthesis of bacteria by binding to specific residues and inhibiting the polymer membrane. It works by killing the bacteria which can cause serious infections.

Uses of Teicoplanin

It is used in adults and children to treat bacterial infections of soft tissues, lungs, urinary tract, endocarditis, abdominal wall, blood, bones, and joints. It works by killing the bacteria that cause infections in the body.

Teicoplanin Dosage available

Teicoplanin is available as an injection. It will be given to you by a doctor or other healthcare professional. It will be given as an intravenous injection (into a vein) or intramuscular (into a muscle). It can also be given as an infusion through a drip into a vein. Your healthcare provider will decide the dose, route of administration, and duration of the treatment based on your health condition and other factors. Do not self-administer the medicine.

We can ship to :

FAQ’s

News/Updates

References

  1. Targocid 400mg powder for solution for injection/infusion or oral solution – Patient Information Leaflet (PIL) – (emc). www.medicines.org.uk. [revised 2022] [cited 2023 Jun 3]. Available from: https://www.medicines.org.uk/emc/product/2927/pil
  2. Camille E. Beauduy, Lisa G. Winston, Beta-Lactam & Other Cell Wall- & Membrane-Active Antibiotics, Lange’s Basic & Clinical Pharmacology, 14th Edition, 2018, 795-814.
  3. KD Tripathi, Macrolide, Lincosamide, Glycopeptide and other Antibacterial Antibiotics, Essentials of Medical Pharmacology, 8th Edition, 2019, 801-814.